Adial Pharmaceuticals Inc (NASDAQ: ADIL) Stock Information | RedChip

Adial Pharmaceuticals Inc (NASDAQ: ADIL) Listen to this Section


$0.98
+0.0149 ( +1.54% ) 167.0K

Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is for the treatment of alcohol use disorder. The active ingredient in AD04 is ondansetron, a serotonin-3 antagonist.

Market Data


Open


$0.98

Previous close


$0.97

Volume


167.0K

Market cap


$4.10M

Day range


$0.94 - $1.00

52 week range


$0.77 - $4.46

Insider Ownership Transactions

Total Amount Purchased: -174,300.00 | $ -170,814.00

Date Type Amount Purchased Purchaser
2024-03-27 Sale -42000.00 Goodman Tony
2024-03-27 Sale -12000.00 Schuyler Kevin
2024-03-27 Sale -12000.00 Anderson J. Kermit
2024-03-27 Sale -60000.00 Claiborne Cary J
2024-03-27 Sale -25000.00 Truluck Joseph
2024-03-27 Sale -12000.00 Newman James W. Jr.
2024-03-27 Sale -12000.00 Gilliland Robertson H.
2023-10-03 Buy 700.00 Schuyler Kevin

SEC Fillings


Form Type Description Pages Date
10-q Quarterly Reports 61 Aug 13, 2024
10-q Quarterly Reports 61 May 14, 2024
8-k 8K-related 14 Apr 26, 2024
8-k 8K-related 16 Apr 18, 2024
8-k 8K-related 13 Apr 16, 2024
10-k Annual reports 76 Apr 01, 2024
4 Insider transactions 1 Mar 27, 2024
4 Insider transactions 1 Mar 27, 2024
4 Insider transactions 1 Mar 27, 2024
4 Insider transactions 1 Mar 27, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.